An Advanced Facility for Breakthrough Depression Treatments

The Dallas Center for Advanced Depression Treatments (CADT) is a safe, comfortable and certified treatment center offering innovative therapies for treatment-resistant depression.

Schedule Consultation

Next-Level Care from Top Professionals

We deliver next-level care for patients whose depression has not responded to medication or psychotherapy, offering relief through several new, non-invasive treatments that are FDA approved for treatment-resistant major depressive disorder (MDD), obsessive-compulsive disorder (OCD) and bipolar disorders.

Our mission is to partner and collaborate with community psychiatric providers, offering patients access to novel interventions in a safe and professional environment.

FAQs for Providers Provider Referral Form

“I am confident when I refer patients to the Dallas CADT that they will receive individualized care in a comfortable and professional environment.”

Stephen Vobach, Dallas Psychiatrist

Multiple Treatments Available

SPRAVATO® Nasal Spray

We are the first and most experienced provider in DFW for SPRAVATO nasal spray, a rapidly acting agent for severely depressed patients. Not only have SPRAVATO trials shown the therapy to be effective, but improvement can be evident within the first 24 hours. SPRAVATO can be a lifeline for adult patients who have not responded adequately to two different antidepressants. SPRAVATO is FDA-approved for treatment-resistant depression.

BrainsWay Deep TMS

At the forefront of scientific breakthroughs for MDD and OCD, BrainsWay Deep TMS is the only 20-minute TMS treatment protocol. An independent study published in 2019 by the Journal of Psychiatric Research determined that Deep TMS plus medication was more effective at reducing depression levels among MDD patients compared with standard rTMS plus medication or medication alone. BrainsWay Deep TMS is FDA-approved for MDD, OCD and smoking cessation.

Intranasal Ketamine

Ketamine can be used to improve depressive symptoms and can be delivered through multiple routes. We offer intranasal administration as a less invasive and affordable alternative to IV ketamine for difficult to treat MDD, bipolar depression and post-traumatic stress disorder (PTSD).

Abilify Maintena

Abilify Maintena is the first and only FDA-approved, once-monthly maintenance treatment for patients with bipolar 1 disorder. This medication has been proven to give more time without a mood episode. In a one-year clinical trial, those who were treated with Abilify Maintena (73%) remained mood episode-free significantly longer than those who were on a placebo. Once-monthly dosing means one less pill patients have to take every day for bipolar 1.

Request a Consultation

If you are a physician or mental health professional and wish to consult with us in advance about a patient referral, please enter your contact information and we will respond within 24 hours.